Table 2.
Operative data and postoperative adverse outcomes after eTHE
| eTHE (n = 166) | |
|---|---|
| Operating time (min) | 380 (88) |
| Blood loss (ml) | 500 (238) |
| Clavien-Dindoa | |
| I | 32 (19.3) |
| II | 60 (36.1) |
| III | 19 (11.4) |
| IV | 12 (7.2) |
| V | 3 (1.8) |
| Vocal cord paresis/paralysisa | |
| Transient | 18 (10.8) |
| Permanent | 1 (0.6) |
| Anastomotic leaka | 19 (11.4) |
| Reoperation overalla | 9 (5.4) |
| Revision for leakagea | 3 (1.8) |
| SSIa | 16 (9.6) |
| Cardiovascular complicationsa | 51 (30.7) |
| Hospital-acquired pneumoniaa | 21 (12.7) |
| ARDSa | 4 (2.4) |
| In-hospital mortalitya | 2 (1.2) |
| 30-day mortalitya | 3 (1.8) |
| 90-day mortalitya | 7 (4.2) |
| Total hospital LOS | 17 (12.0) |
Values are medians (interquartile ranges) unless indicated otherwise
eTHE extended transhiatal esophageal resection with radical bilateral mediastinal en bloc lymphadenectomy, ARDS acute respiratory distress syndrome, SSI surgical site infection, LOS length of stay
a Values are numbers (percentages)